[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Iradimed Corp (IRMD)

Iradimed Corp (IRMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
iRadimed Corporation engages in developing, manufacturing, marketing, and distributing magnetic resonance imaging (MRI) compatible products. It offers non-magnetic intravenous (IV) infusion pump systems, IV tubing sets, IV poles, wireless remote displays/controls under the mRidium name; side car pump modules; dose error reduction systems; Masimo SET SpO2 monitoring products; and MRI Pulse oximeters, and MRI oximeter remotes and displays under the iMagox name used during MRI procedures. iRadimed Corporation is headquartered in Winter Park, Florida.

Fiscal Year End Date: 12/31

(Values in U.S. Thousands) Mar, 2026 Dec, 2025 Sep, 2025 Jun, 2025 Mar, 2025
Sales 21,980 22,690 21,200 20,410 19,510
Sales Growth -3.13% +7.03% +3.87% +4.61% +0.62%
Net Income 5,820 6,440 5,580 5,770 4,690
Net Income Growth -9.63% +15.41% -3.29% +23.03% -8.93%
(Values in U.S. Thousands) Mar, 2026 Dec, 2025 Sep, 2025 Jun, 2025 Mar, 2025
Total Assets 114,390 108,780 114,720 106,450 101,730
Total Assets Growth +5.16% -5.18% +7.77% +4.64% +3.46%
Total Liabilities 15,880 14,160 16,370 12,150 11,680
Total Liabilities Growth +12.15% -13.50% +34.73% +4.02% +1.48%
(Values in U.S. Thousands) Mar, 2026 Dec, 2025 Sep, 2025 Jun, 2025 Mar, 2025
Operating Cash Flow 8,290 24,950 19,020 12,040 4,290
Operating Cash Flow Growth -66.77% +31.18% +57.97% +180.65% -83.26%
Net Cash Flow 5,220 -1,080 4,290 760 -1,900
Change in Net Cash Flow +583.33% -125.17% +464.47% +140.00% -176.92%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.